Please note, this OEL/ADE monograph also applies to quinidine sulfate (CAS RN 6591-63-5), quinidine sulfate anhydrous (CAS RN 50-54-4), quinidine bisulfate (CAS RN 747-45-5), quinidine gluconate (CAS RN 7054-25-3), quinidine hydrochloride (CAS RN 1668-99-1), and quinidine hydrochloride monohydrate (CAS RN 6151-40-2). Quinidine is a class 1A antiarrhythmic. It also has antimuscarinic and alpha-adrenoceptor blocking properties. Quinidine is used in the management of supraventricular and ventricular arrhythmias, including cardioversion and maintenance of sinus rhythm in atrial fibrillation, but other drugs or methods are usually preferred. Quinidine is an isomer of quinine and may be used as an alternative to quinine in the treatment of malaria when quinine is not immediately available.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API).
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL monograph for Quinidine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.